Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Sunshine Biopharma ( (SBFM) ).
Sunshine Biopharma has announced the appointment of Mr. Michel Roy as its new Chief Commercial Officer. Mr. Roy brings extensive experience from major international pharmaceutical companies and will be responsible for driving the company’s commercial strategy, which includes sales, marketing, and business development. His leadership is expected to contribute significantly to Sunshine Biopharma’s growth and market expansion.
More about Sunshine Biopharma
Sunshine Biopharma is a pharmaceutical company that focuses on researching and offering life-saving medicines across various therapeutic areas, including oncology and antivirals.
YTD Price Performance: -9.90%
Average Trading Volume: 706,314
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $7.64M
Learn more about SBFM stock on TipRanks’ Stock Analysis page.
